-
May 15, 2012
University of Chicago contributes monoclonal antibodies for Ovalbumin, Major Histocompatability Complex (MHC) variants, and Inosine-5'-monophosphate (IMP) Dehydrogenase to The Investigator’s Annexe™ at KeraFAST.
May 10, 2012
Pavel A. Petukhov, PhD of University of Illinois at Chicago contributes Photoreactive HDAC Inhibitors to The Investigator’s Annexe™ at KeraFAST.
May 4, 2012
Anthony Frankfurter, PhD and Anthony Spano, PhD of University of Virginia contribute Anti-Class VI Beta Tubulin (AA16) Monoclonal Antibody to The Investigator’s Annexe™ at KeraFAST.
May 3, 2012
Lawrence Pfeffer, PhD of University of Tennessee contributes an Antisense miR-21 Lentivirus and Recombinant p65-GST Protein to The Investigator’s Annexe™ at KeraFAST.
April 26, 2012
Glenn R. Gaudette, Ph.D. and George D. Pins, Ph.D. of Worcester Polytechnic Institute contribute Fibrin Microthread for Stem Cell Delivery to The Investigator’s Annexe™ at KeraFAST.
April 19, 2012
Michael A. Whitt, Ph.D. of University of Tennessee contributes Recombinant Vesicular Stomatitis Virus ΔG System to The Investigator’s Annexe™ at KeraFAST.
March 29, 2012
Shu-Chan Hsu, Ph.D. of Rutgers University contributes Exocyst Antibodies to The Investigator’s Annexe™ at KeraFAST.
Shigeko Yamashiro, Ph.D. and Fumio Matsumura, Ph.D. of Rutgers University contribute Fascin-1 monoclonal antibody to The Investigator’s Annexe™ at KeraFAST.
March 28, 2012
Yaowu Hao, Ph.D of University of Texas-Arlington contributes Hollow Gold Nanoparticles to The Investigator’s Annexe™ at KeraFAST.
March 23, 2012
Florida State University contributes Recombinant Fibroblast Growth Factors and Kallikrein-Related Peptidase to The Investigator’s Annexe™ at KeraFAST.
March 22, 2012
KeraFast Closes on Series A Financing with FCA Venture Partners to Scale its Unique Marketplace for Life Science Research Products.
March 20, 2012
Purdue University joins The Investigator’s Annexe™ at KeraFAST.
University of Vermont joins The Investigator’s Annexe™ at KeraFAST.
March 8, 2012
Woods Hole Oceanographic Institute joins The Investigator’s Annexe™ at KeraFAST.
Worcester Polytechnic Institute joins The Investigator’s Annexe™ at KeraFAST.
March 2, 2012
Medical College of Wisconsin joins The Investigator’s Annexe™ at KeraFAST.
March 1, 2012
University of Texas-Arlington joins The Investigator’s Annexe™ at KeraFAST.
February 24, 2012
Dr. Kenneth H. Roux of Florida State University adds Human IgE Protein to The Investigator’s Annexe™ at KeraFAST.
February 15, 2012
SUNY-Upstate joins The Investigator’s Annexe™ at KeraFAST. January 31, 2012
ViraQuest, Inc brings premade adenovirus vectors to the KeraFAST Partners Program. January 19, 2012
Dr. Gregory G. Tall of University of Rochester adds G Protein Subunits to The Investigator’s Annexe™ at KeraFAST.
January 18, 2012
Eptiope Biotech, Inc brings monoclonal antibodies for specific tag and loading control epitopes to the KeraFAST Partners Program.
December 21, 2011
Dr. Clifford J. Rosen of Maine Medical Center Research Institute adds Bone Immunoassay services to The Investigator’s Annexe™ at KeraFAST.
December 20, 2011
East Carolina University joins The Investigator’s Annexe™ at KeraFAST.
Cellomics Technology brings premade lentivirus particles for stable transduction and generation of iPS cells to the KeraFAST Partners Program.
December 19, 2011
Children's Hospital Boston joins The Investigator’s Annexe™ at KeraFAST.
Dr. Choogon Lee of Florida State University brings Circadian Clock Regulator Antibodies to The Investigator’s Annexe™ at KeraFAST
December 15, 2011
Dr. Yuntao Wu of George Mason University brings Rev-Dependent HIV Indicator T-Cell Line to The Investigator’s Annexe™ at KeraFAST
-
December 8, 2011.
-
Maine Manufacturing brings the gold standard protein microarray platform, FAST® Slides, to the KFP, KeraFAST Partner program.
December 7, 2011 -
Dr. Daniel Cox of George Mason University brings a Tissue Mounting Membrane for increased tissue retention during histology processing to The Investigator’s Annexe™ at KeraFAST
November 11, 2011
Dr. Philip Keehn, Brandeis University, adds a broad portfolio of unique chemical compounds to The Investigator’s Annexe™ at KeraFAST.
November 10, 2011
- Cancer Research Technology (CRT) contributes monoclonal antibodies for oncology and epigenetics research to The Investigator’s Annexe™ at KeraFAST. CRT is the cancer-focused technology development and commercialization arm of Cancer Research UK.
November 7, 2011
Dr. Leslie B. Poole of Wake Forest University contributes Protein Cysteine Oxidation Probes for studying cysteine sulfenic acid formation to The Investigator’s Annexe™ at KeraFAST.
November 4, 2011
McGill University joins The Investigator’s Annexe™ at KeraFAST.
November 1, 2011
CalAsia Pharmaceuticals brings a range of recombinant human and rodent proteins to the KFP, KeraFAST Partner program.
October 13, 2011
George Mason University joins The Investigator’s Annexe™ at KeraFAST.
October 11, 2011
Dr. Keith Reimann, Beth Israel Deaconess Medical Center, brings anti-macaque and anti-human IgGs to The Investigator’s Annexe™ at KeraFAST.
September 21, 2011
Florida State University joins The Investigator’s Annexe™ at KeraFAST.
September 15, 2011
Xtal Biostructures contributes recombinant human histones to the KFP, KeraFAST Partner program.
September 9, 2011
Brighter Ideas, Inc. brings Green Fluorescent Protein reagents to the KFP, KeraFAST Partner program.
August 31, 2011
Dr. Kenan Murphy of University of Massachusetts Medical School contributes Recominbeering Plasmids for Gene Replacement in Bacteria to The Investigator’s Annexe™ at KeraFAST.
August 19, 2011
Dr. Bruce King, Wake Forest University, adds Nitroxyl (HNO) donors and detectors to The Investigator’s Annexe™ at KeraFAST.
August 5, 2011
Dr. Lawrence Pfeffer of the University of Tennessee contributes STAT2-Defective Daudi Cells to The Investigator’s Annexe™ at KeraFAST.
August 1, 2011
SBH Sciences brings unique Recombinant Cytokines, Anti-Cytokine Monoclonal Antibodies and Laboratory Services to the KFP, KeraFAST Partner program.
July 26, 2011
Dr. Dongfeng Pan of the University of Virginia contributes a Neutrophil-Specific, NIR Fluorescent Imaging Agent to The Investigator’s Annexe™ at KeraFAST.
July 26, 2011
Dr. Ian Macara of the University of Virginia adds a Sept6 monoclonal antibody to The Investigator’s Annexe™ at KeraFAST.
July 22, 2011
Dr. Tom Hollis, Wake Forest University, brings the Protein/Nucleic Acid Crystal Screen to The Investigator’s Annexe™ at KeraFAST.
June 15, 2011
Monoclonal antibodies to Caspases and other Cell Death Pathway proteins were contributed to The Investigator’s Annexe™ at KeraFAST by Harvard University.
June 8, 2011
Dr. Roger Jones of Rutgers University contributes Cyclic-di-GMP to The Investigator’s Annexe™ at KeraFAST.
May 24, 2011
Monoclonal antibodies to transcription factor E2F contributed to The Investigator’s Annexe™ at KeraFAST by a major Cambridge MA university.
April 22, 2011
Pressure Biosciences, Inc. adds PSI Shredder sample prep technology to the KFP, KeraFAST Partner Program.
March 21, 2011
Stratec Molecular adds a full line of DNA/RNA prep kits to KFP, the KeraFAST Partner Program.
January 31, 2011 Dr. Paul Leavis from Boston Biomedical Research Institute, adds unique peptides and derivatives to The Investigator’s Annexe™ at KeraFAST.
December 20, 2010
Dr. James Sherley, Adult Stem Cell Technology Center, Boston Biomedical Research Institute, contributes rodent and human adult stem cells to The Investigator’s Annexe™ at KeraFAST.
December 20, 2010
Dr. Douglas Lyles, Wake Forest University, brings VSV hybridomas and plasmids to The Investigator’s Annexe™ at KeraFAST.
December 14, 2010
Techulon adds Glycofect™ transfection agent to KeraFAST Partner Program.
Dec. 7, 2010
BioStorage Lab Services adds Epstein Barr Virus to KFP, the KeraFAST Partner Program.
-